14-day Premium Trial Subscription Try For FreeTry Free
Shares of Cutera Inc. fell hard after hours on Tuesday after the maker of skincare and body-sculpting devices — currently engulfed in drama over a leadership changeover — reported weaker quarterly
Cutera (CUTR) came out with a quarterly loss of $0.80 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.32 per share a year ago.

New Strong Sell Stocks for May 1st

06:51am, Monday, 01'st May 2023
AOMR, BMRN and CUTR have been added to the Zacks Rank #5 (Strong Sell) List on May 1, 2023.

Easy Channel Check Shows Cutera Has A Hit Product

06:00am, Saturday, 29'th Apr 2023
Cutera has sold off on major boardroom drama. CUTR has successfully launched AviClear, the biggest advance in acne treatment in decades.
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report finan
Cutera Inc. CUTR, a maker of devices used for skincare and body-sculpting, on Thursday said it would hold a special shareholder meeting on June 9 to weigh whether to remove five directors — the late
Cutera Inc. CUTR, a Californian provider of dermatology equipment, said Wednesday it's terminating its executive chairman Daniel Plants and chief executive David Mowry for cause, on the recommendation

New Strong Sell Stocks for April 6th

09:11am, Thursday, 06'th Apr 2023
CUTR, AMPS and CPE have been added to the Zacks Rank #5 (Strong Sell) List on April 6, 2023.
While an extremely risky proposition, short-squeeze stocks – as meme traders demonstrated – can occasionally yield radical profitability. However, you don't want to just pick any beaten-down secur
Short sellers are getting bold again. And they've picked their favorite stock market targets to crash.
Cutera, Inc. (NASDAQ:CUTR ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Dave Mowry - Chief Executive Officer Rohan Seth - Chief Financial Officer Conference Call
Cutera (CUTR) delivered earnings and revenue surprises of 62.07% and 0.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report finan
Cutera (CUTR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE